The Global Coronary Stents Market
, by Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), by Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable / Permanent Stents and Degradable / Temporary Stents)), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
is estimated to be valued at US$ 7,814.4 million
in 2018, and is projected to exhibit a CAGR of 6.8%
over the forecast period (2018 – 2026) as highlighted in a new report published by .
Coronary stents are small wired mesh-like medical interventional devices used for treatment of narrowed arteries. Increasing incidence of coronary blockage and changes in lifestyle from physically active to sedentary lifestyle, in turn is increasing cholesterol accumulation, and in turn aiding the coronary stents market growth. For instance, according to World Health Organization (WHO) 2017 survey, the global prevalence of obesity increased by three times between 1975 and 2016.
The trajectory growth in the coronary stents market can be attributed to increasing number of product launches in the market. Intense competition and pricing pressure is compelling manufacturers to develop cost-effective and innovative stents in the market.
For instance, in 2017, Medtronic received approval for Onyx drug eluting stents from the U.S. FDA for the treatment of coronary artery disease in adults. In the same year, company also received approval for cobalt chromium coronary stent system, known as Pro-Kinetic energy stents after BIOHELIX-I studies.
Furthermore, in 2017, Cordis launched two products: the Tryton Side Branch Stent and Medinol’s NIRxcell, a cobalt-chromium bare metal stent (BMS) under comprehensive interventional cardiology portfolio at 29th Transcatheter Cardiovascular Therapeutics Symposium. Such product launches in symposiums and conferences are expected to highlight the product and its features to healthcare professionals and distributors, in turn aiding in increasing the customer base of the company.
Browse Market Data 32 Tables and 30 Figures spread through 155 Pages and in-depth TOC on "Coronary Stents Market, by Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), by Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable / Permanent Stents and Degradable / Temporary Stents)), by End User (Hospitals, Specialty Clinics and Ambulatory Surgical Centers) and by Region - Global Forecast to 2026”
To know the latest trends and insights related to coronary stents market, click the link below:
Mergers and acquisition by key players are further augmenting the coronary stents market growth with major players enhancing their market share and leveraging the strengths of the acquired company. For instance, in February 2018, Stentys confirms its rights to acquire MINVASYS, a France-based cardiovascular disorder solutions specialist, to accelerate its development and to establish as a benchmark in interventional cardiology market.
Key takeaways of the Coronary Stents Market:
- The global coronary stents market is expected to expand at a CAGR of 6.8% during the forecast period (2018 – 2026), owing to increasing competition amongst market players to launch new products
- Bare-metal stents segment accounts for the largest share in product type segment, owing to wide product range and its application. Bare metal stents are oldest segment in coronary stents with wide variety of stents available with different metal and its alloys
- Polymeric stents segment is expected to exhibit the highest CAGR, over the forecast period, owing to its benefits over metallic stents encouraging more product launches in this segment. Metallic stents leads to complications such as thrombosis or hyper-reactivity which are less common in polymeric stents as they are more biocompatible.
- Some of the major players operating in the global coronary stents market are Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA